Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 47INDUSTRY 12NIH 10OTHER_GOV 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 90Other hematologic neoplasm 58Breast 42CNS 31Sarcoma 24Plasma cell 20Genitourinary 8Myeloid 6Gynecologic 4Classical hematology 4Dermatologic 3Other neoplasm 2Thoracic 1Other solid neoplasm 1Endocrine 1

Conditions

Wilms Tumor 1Sarcoma 1Retinoblastoma 1Neuroblastoma 1Kidney Neoplasms 1Adrenocortical Carcinoma 1

Interventions

Cisplatin 6Pemetrexed 5Carboplatin 4Standard of Care 3Specimen Handling 3Practice Guidelines as Topic 3Interviews as Topic 3Immunoenzyme Techniques 3Docetaxel 3raltitrexed 2Vincristine 2Trabectedin 2N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide 2Irinotecan 2Immunohistochemistry 2Gemcitabine 2Etoposide 2Early Intervention, Educational 2Bortezomib 2AEG 35156 2temsirolimus 1sabarubicin 1pembrolizumab 1nintedanib 1halofuginone 1ascrinvacumab 1Triptorelin Pamoate 1Thrombopoietin 1Theophylline 1SB939 compound 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Cyclophosphamide × Other solid neoplasm × Clear all
NCT01048892 2014-01-30

Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features

Children's Oncology Group

Phase 1 Completed
22 enrolled
CNSEndocrineGenitourinaryOther solid neoplasmSarcoma

Kidney Neoplasms, Wilms Tumor, Neuroblastoma, Retinoblastoma, Sarcoma, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡